Cell therapy weekly: MSCs show promise to treat rare pediatric heart condition
This week: Longeveron treats first patient with MSCs, Duchenne muscular dystrophy improved in mouse model and new funding for development of synthetic ‘gene circuits.
Please sign in or register for FREE
Sign in to RegMedNet
Not yet a member? Become a member FREE to:
- Get unlimited access to ALL CONTENT
- Read selected articles from journals such as Regenerative Medicine FREE
- Receive a weekly email roundup of the latest news and expert opinions
Did you know?
Your RegMedNet account also gives you access to communities on drug discovery, real-world evidence and 3D printing in medicine. Find out more>>